Australia may need to turn to India for its future CROs needs. In this rocky climate, it proves to be the most cost-efficient way for Australians to develop new and innovative drugs. They are the number one location for biotechnology in the Pacific region and sixth in the world for developing drugs. Read more here.
Rashmi H. Barbhaiya, founder and CEO of Bangalore-based Advinus Therapeutics Pvt Ltd, had this to say about the possibilities:
"Australia has phenomenal strength in basic research in early drug discovery and identifying disease targets. My perception is to somehow translate this early drug discovery into identifying drug candidates for pre-clinical trials and clinical trials, wherein lies India’s strength."
Search This Blog
Blog Archive
-
▼
2008
(97)
-
▼
October
(16)
- India possibility for Australia's CROs Needs
- CRO Stock Prices Going Down
- CROs Open New Opportunities for Employment
- Clinical Outsourcing Spend is Going Down
- Reducing Costs and Time of Cancer Trials
- Pharma Companies Are Outsourcing Less of Clinical ...
- Are companies budgeting less towards their outsour...
- Averion expands in Eastern Europe
- New report focusing on outsourcing in central Europe
- ethica Clinical Research expands to South America
- Clincal Trials in India
- Clinical Trials Today: ethica Heads to South America
- Bridge Laboratories to Support NIDA
- Changing Face of CRO's
- Update to China’s Growing Lead in Clinical Outsour...
- China is Ahead of India in Outsourced Trials
-
▼
October
(16)
No comments:
Post a Comment